类模拟剂是开发JAK-STAT通路新调节剂的首选化合物吗?
Alessia Cugudda1, Sara La Manna1, Daniela Marasco1
1Department of Pharmacy, University of Naples "Federico II", Naples, Italy.
Frontiers in immunology
|July 10, 2024
概括
宏观循环是调节蛋白质与蛋白质相互作用 (PPI) 的有希望的蛋白质模拟剂. 这项研究侧重于针对 Janus 激酶/信号传感器和转录激活器 (JAK-STAT) 途径的类宏循环,用于治疗应用.
科学领域:
- 生物化学和分子生物学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白与蛋白相互作用 (PPI) 对细胞功能至关重要,其失调与癌症和神经退行等疾病有关.
- 用新型化学调节剂准失调的PPI对于推进向疗法至关重要.
- 宏循环,特别是类宏循环,由于其有利的物理化学特性,正在成为有效的蛋白模仿剂.
研究的目的:
- 探索宏环皮多米米特剂作为PPI调节剂的潜力.
- 专注于向Janus激酶/信号传感器和转录激活器 (JAK-STAT) 信号通路的宏环化合物.
- 突出宏观循环在与途径功能障碍相关的疾病的药物发现中的作用.
主要方法:
- 审查和分析现有的关于宏环皮多米米特的文献.
- 专注于旨在模仿蛋白质结构和调节PPI的化合物.
- 检查针对JAK-STAT信号通路的宏观循环.
主要成果:
- 宏观循环为PPI调节提供了小分子和蛋白质之间的独特化学空间.
- 类宏循环在调节关键生物通路方面显示出显著的潜力.
- 基于宏观循环的治疗方法中,JAK-STAT途径是一个相关的目标.
结论:
- 宏循环皮相仿剂代表了开发针对PPI失调驱动的疾病的新疗法的一项有价值的战略.
- 用宏循环准JAK-STAT通路对治疗炎症,癌症和神经退行性疾病有很大的希望.
- 宏观循环的独特特性使得它们在现代药物发现工作中占据着突出地位.
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
01:22Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
01:24Glucagon-like Receptor Agonists
313
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
313
01:16TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K